Sara Secall

Life Sciences Investment Director & Board Member at Connecta Therapeutics

Sara Secall is responsible for building the Biotech Portfolio in Inveready. Sara has an extensive international career investing in technology. She was involved in investing and exiting several Venture Capital investments while working for Chevron Technology Ventures, the corporate venture capital group based in California with USD 210 MM under management. Prior to joining Inveready, as Director of Spin Outs for the University of Barcelona, she was involved in starting and financing over 25 technology startups and negotiated numerous technology licenses, mainly in the biotechnology sector. She has worked extensively in the USA, Latin America and Europe. Sara holds a BS in Chemistry, MSc in Environmental Sciences from Indiana University and an MBA from the London Business School.

Links